BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36299430)

  • 1. Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave.
    Tan ST; Kwan AT; Rodríguez-Barraquer I; Singer BJ; Park HJ; Lewnard JA; Sears D; Lo NC
    medRxiv; 2022 Nov; ():. PubMed ID: 36299430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave.
    Tan ST; Kwan AT; Rodríguez-Barraquer I; Singer BJ; Park HJ; Lewnard JA; Sears D; Lo NC
    Nat Med; 2023 Feb; 29(2):358-365. PubMed ID: 36593393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    Babouee Flury B; Güsewell S; Egger T; Leal O; Brucher A; Lemmenmeier E; Meier Kleeb D; Möller JC; Rieder P; Rütti M; Schmid HR; Stocker R; Vuichard-Gysin D; Wiggli B; Besold U; McGeer A; Risch L; Friedl A; Schlegel M; Kuster SP; Kahlert CR; Kohler P;
    PLoS Med; 2022 Nov; 19(11):e1004125. PubMed ID: 36342956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Quick Displacement of the SARS-CoV-2 variant Delta with Omicron: Unprecedented Spike in COVID-19 Cases Associated with Fewer Admissions and Comparable Upper Respiratory Viral Loads.
    Fall A; Eldesouki RE; Sachithanandham J; Morris CP; Norton JM; Gaston DC; Forman M; Abdullah O; Gallagher N; Li M; Swanson NJ; Pekosz A; Klein EY; Mostafa HH
    medRxiv; 2022 Jan; ():. PubMed ID: 35118480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2.
    Puhach O; Adea K; Hulo N; Sattonnet P; Genecand C; Iten A; Jacquérioz F; Kaiser L; Vetter P; Eckerle I; Meyer B
    Nat Med; 2022 Jul; 28(7):1491-1500. PubMed ID: 35395151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark.
    Lyngse FP; Kirkeby CT; Denwood M; Christiansen LE; Mølbak K; Møller CH; Skov RL; Krause TG; Rasmussen M; Sieber RN; Johannesen TB; Lillebaek T; Fonager J; Fomsgaard A; Møller FT; Stegger M; Overvad M; Spiess K; Mortensen LH
    Nat Commun; 2022 Sep; 13(1):5760. PubMed ID: 36180438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, Canada.
    Carazo S; Skowronski DM; Brisson M; Sauvageau C; Brousseau N; Gilca R; Ouakki M; Barkati S; Fafard J; Talbot D; Gilca V; Deceuninck G; Garenc C; Carignan A; De Wals P; De Serres G
    JAMA Netw Open; 2022 Oct; 5(10):e2236670. PubMed ID: 36239934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Likelihood of infecting or getting infected with COVID-19 as a function of vaccination status, as investigated with a stochastic model for Aotearoa New Zealand for Delta and Omicron variants.
    Watson LM
    N Z Med J; 2022 Apr; 135():89-100. PubMed ID: 35728188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of primary series and booster vaccination against SARS-CoV-2 infection and hospitalisation among adolescents aged 12-17 years in Singapore: a national cohort study.
    Chiew CJ; Premikha M; Chong CY; Wei WE; Ong B; Lye DC; Heng D; Lee VJ; Tan KB
    Lancet Infect Dis; 2023 Feb; 23(2):177-182. PubMed ID: 36182678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Infection Rates in Vaccinated and Unvaccinated Inmates: A Retrospective Cohort Study.
    Ko L; Malet G; Chang LL; Nguyen H; Mayes R
    Cureus; 2023 Sep; 15(9):e44684. PubMed ID: 37680261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections.
    Qassim SH; Hasan MR; Tang P; Chemaitelly H; Ayoub HH; Yassine HM; Al-Khatib HA; Smatti MK; Abdul-Rahim HF; Nasrallah GK; Al-Kuwari MG; Al-Khal A; Coyle P; Gillani I; Kaleeckal AH; Shaik RM; Latif AN; Al-Kuwari E; Jeremijenko A; Butt AA; Bertollini R; Al-Romaihi HE; Al-Thani MH; Abu-Raddad LJ
    Front Immunol; 2022; 13():984784. PubMed ID: 36177014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission potential of vaccinated and unvaccinated persons infected with the SARS-CoV-2 Delta variant in a federal prison, July-August 2021.
    Salvatore PP; Lee CC; Sleweon S; McCormick DW; Nicolae L; Knipe K; Dixon T; Banta R; Ogle I; Young C; Dusseau C; Salmonson S; Ogden C; Godwin E; Ballom T; Rhodes T; Wynn NT; David E; Bessey TK; Kim G; Suppiah S; Tamin A; Harcourt JL; Sheth M; Lowe L; Browne H; Tate JE; Kirking HL; Hagan LM
    Vaccine; 2023 Mar; 41(11):1808-1818. PubMed ID: 36572604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between COVID-19 Vaccination and SARS-CoV-2 Infection among Household Contacts of Infected Individuals: A Prospective Household Study in England.
    Muhsen K; Waight PA; Kirsebom F; Andrews N; Letley L; Gower CM; Skarnes C; Quinot C; Lunt R; Bernal JL; Flasche S; Miller E
    Vaccines (Basel); 2024 Jan; 12(2):. PubMed ID: 38400097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against Omicron conferred by mRNA primary vaccine series, boosters, and prior infection.
    Chin ET; Leidner D; Lamson L; Lucas K; Studdert DM; Goldhaber-Fiebert JD; Andrews JR; Salomon JA
    medRxiv; 2022 May; ():. PubMed ID: 35665013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study.
    Gazit S; Shlezinger R; Perez G; Lotan R; Peretz A; Ben-Tov A; Herzel E; Alapi H; Cohen D; Muhsen K; Chodick G; Patalon T
    Clin Infect Dis; 2022 Aug; 75(1):e545-e551. PubMed ID: 35380632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vaccination on household transmission of SARS-CoV-2 Delta variant of concern.
    Lyngse FP; Mølbak K; Denwood M; Christiansen LE; Møller CH; Rasmussen M; Cohen AS; Stegger M; Fonager J; Sieber RN; Ellegaard KM; Nielsen C; Kirkeby CT
    Nat Commun; 2022 Jun; 13(1):3764. PubMed ID: 35773247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary SARS-CoV-2 Infections, Re-infections and Vaccine Effectiveness during the Omicron Transmission Period in Healthcare Workers of Trieste and Gorizia (Northeast Italy), 1 December 2021-31 May 2022.
    Cegolon L; Negro C; Mastrangelo G; Filon FL;
    Viruses; 2022 Nov; 14(12):. PubMed ID: 36560692
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluating risk factors associated with COVID-19 infections among vaccinated people early in the U.S. vaccination campaign: an observational study of five states, January-March 2021.
    Sadigh KS; Kugeler KJ; Bressler S; Massay SC; Schmoll E; Milroy L; Cavanaugh AM; Sierocki A; ; Fischer M; Nolen LD
    BMC Infect Dis; 2022 Sep; 22(1):718. PubMed ID: 36050630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.